Annual Report 10/11
Q1 • Results from Phase I study in cancer pain shows promising safety data and relief of chronic pain Q2 • Recruitment for US Phase III study in type 1 diabetes is completed • Phase II study in cancer pain is started • University of Florida Research Foundation initiates court case against Diamyd Medical Q3 • Results of a Phase I clinical study in cancer pain is published in the medical journal Annals of Neurology • Peter Zerhouni is appointed President and CEO of Diamyd Medical AB • Results are announced from European Phase III study in type 1 diabetes, which did